Sofie H. Tolmeijer - Concepedia

Author

Sofie H. Tolmeijer

Radboud University Nijmegen ORCID

Also Known As

S.H. Tolmeijer, Sofie H Tolmeijer, Sofie H. Tolmeijer, Sofie Tolmeijer

132

Publications

567

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen University of British Columbia Radboud University Medical Center Canada's Michael Smith Genome Sciences Centre Tampere University

About

Sofie H. Tolmeijer is an author at Radboud University Nijmegen.

Sofie H. Tolmeijer

Publications

414

Citations

H-Index

Page 1

	Year	Citations
Glucocorticoids inhibit macrophage differentiation towards a pro-inflammatory phenotype upon wounding without affecting their migration Yufei Xie, Sofie H. Tolmeijer, Jelle M. Oskam, Disease Models & Mechanisms	2019	104
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer Nicolette M. Fonseca, Corinne Maurice‐Dror, Cameron Herberts, Nature Communications	2024	101
Metabolic stress in cancer cells induces immune escape through a PI3K-dependent blockade of IFNγ receptor signaling Koen A. Marijt, Marjolein Sluijter, Laura Blijleven, Journal for ImmunoTherapy of Cancer	2019	81
Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer Sofie H. Tolmeijer, Emmy Boerrigter, Takayuki Sumiyoshi, Clinical Cancer Research	2023	50
Circulating Tumor DNA-Based Disease Monitoring of Patients with Locally Advanced Esophageal Cancer Lisa S.M. Hofste, Maartje J. Geerlings, Daniel von Rhein, Cancers	2022	24
Glucocorticoids inhibit macrophage differentiation towards a pro-inflammatory phenotype upon wounding without affecting their migration Yufei Xie, Sofie H. Tolmeijer, Jelle M. Oskam,	2018	19
Lutetium-177–PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial Edmond M. Kwan, Sarah W.S. Ng, Sofie H. Tolmeijer, Nature Medicine	2025	18
Early On-treatment Circulating Tumor DNA Measurements and Response to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer Sofie H. Tolmeijer, Sandra van Wilpe, Maartje J. Geerlings, European Urology Oncology	2023	17

Page 1